Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

The new lawsuit repeats those concerns, alleging that Kennedy and other political appointees at the U.S. Department of Health ...

The acknowledgment that the well-connected Epstein did not have a list of clients to whom underage girls were trafficked ...

Ticker: Wegovy and Zepbound prices fall; ExxonMobil and partner Qatar Energy find new natural gas deposit off Cyprus ...

A 27-year-old man was killed Monday after opening fire at a U.S. Border Patrol facility in McAllen, Texas, authoriti ...

LOS ANGELES (AP) — About 90 members of the California National Guard and over dozen military vehicles like Humvees are ...

In the Hill Country area, home to Camp Mystic and several other summer camps, searchers have found the bodies of 75 people, ...

The disclosure by U.S. lawyer Jonathan Guynn contradicts statements by spokespeople for the Justice Department and the White ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Wegovy received U.S. Food and Drug Administration (FDA) approval and was launched in June 2021, and Zepbound entered the market in December 2023 as a new contender.

"Both Wegovy and Zepbound have demonstrated clinically significant weight reduction." "For example, if a patient has fatty liver, we will choose the GLP-1 that is proven to work best for liver ...

This month, CVS Caremark announced that it had also signed a deal to make Novo Nordisk’s Wegovy its preferred GLP-1RA starting in July, which concurrently deprioritised coverage for Zepbound.